1. Home
  2. STGW vs STOK Comparison

STGW vs STOK Comparison

Compare STGW & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stagwell Inc.

STGW

Stagwell Inc.

SELL

Current Price

$8.98

Market Cap

1.8B

Sector

N/A

ML Signal

SELL

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$24.03

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STGW
STOK
Founded
1980
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
STGW
STOK
Price
$8.98
$24.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
14
Target Price
$10.71
★ $46.46
AVG Volume (30 Days)
★ 1.4M
712.8K
Earning Date
10-29-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 92.73
EPS
N/A
★ N/A
Revenue
★ $2,909,000,000.00
$184,420,000.00
Revenue This Year
$11.55
N/A
Revenue Next Year
$2.84
$39.98
P/E Ratio
N/A
★ N/A
Revenue Growth
2.39
★ 404.50
52 Week Low
$4.29
$20.32
52 Week High
$9.64
$40.22

Technical Indicators

Market Signals
Indicator
STGW
STOK
Relative Strength Index (RSI) 58.00 38.49
Support Level $8.05 N/A
Resistance Level $9.55 $33.92
Average True Range (ATR) 0.31 1.11
MACD 0.07 -0.03
Stochastic Oscillator 56.15 43.10

Price Performance

Historical Comparison
STGW
STOK

About STGW Stagwell Inc.

Stagwell Inc is a challenger network using AI to deliver marketing and advertising solutions to its clients. It operates in five reportable segments: Marketing Services, Digital Transformation, Media and Commerce, Communications, and The Marketing Cloud. Maximum revenue is generated from the Marketing Services segment, which offers social media solutions, designs breakthrough brand campaigns, and creates immersive experiential marketing programs and social engagement strategies, helping clients connect with audiences across digital platforms. The various brands operating under this segment include 72 and Sunny, Anomaly, NRG, Harris Insights, TEAM, and Movers & Shaker. Geographically, the company generates maximum revenue from the United States, followed by the UK and other countries.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: